Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01D OTHER BETA-LACTAM ANTIBACTERIALS
J01DI Other cephalosporins and penems
J01DI54 Ceftolozane and beta-lactamase inhibitor
D10577 Ceftolozane sulfate and tazobactam sodium <JP/US>
USP drug classification [BR:br08302]
Antibacterials
Beta-lactam, Cephalosporins
Ceftolozane Sulfate/ Tazobactam
D10577 Ceftolozane sulfate and tazobactam sodium
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
61 Antibiotics
613 Acting mainly on gram-positive and gram-negative bacteria
6139 Others
D10577 Ceftolozane sulfate and tazobactam sodium
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Other cephalosporin
D10577 Ceftolozane sulfate and tazobactam sodium <JP/US>
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Other cephalosporin
D10577 Ceftolozane sulfate and tazobactam sodium
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10577
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10577
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10577
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10577
